Logo image of CF.CA

CANACCORD GENUITY GROUP INC (CF.CA) Stock Fundamental Analysis

TSX:CF - Toronto Stock Exchange - CA1348011091 - Common Stock - Currency: CAD

10.8  -0.26 (-2.35%)

Fundamental Rating

5

Overall CF gets a fundamental rating of 5 out of 10. We evaluated CF against 82 industry peers in the Capital Markets industry. CF scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CF is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year CF was profitable.
CF had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CF reported negative net income in multiple years.
The reported operating cash flow has been mixed in the past 5 years: CF reported negative operating cash flow in multiple years.
CF.CA Yearly Net Income VS EBIT VS OCF VS FCFCF.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B

1.2 Ratios

CF has a worse Return On Assets (-0.43%) than 70.73% of its industry peers.
Looking at the Return On Equity, with a value of -3.01%, CF is doing worse than 73.17% of the companies in the same industry.
The Return On Invested Capital of CF (3.49%) is better than 69.51% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CF is below the industry average of 7.88%.
Industry RankSector Rank
ROA -0.43%
ROE -3.01%
ROIC 3.49%
ROA(3y)-0.81%
ROA(5y)0.75%
ROE(3y)-5.02%
ROE(5y)5.02%
ROIC(3y)3.66%
ROIC(5y)7.72%
CF.CA Yearly ROA, ROE, ROICCF.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 -40

1.3 Margins

Looking at the Operating Margin, with a value of 11.60%, CF is doing worse than 64.63% of the companies in the same industry.
CF's Operating Margin has been stable in the last couple of years.
CF has a Gross Margin of 94.51%. This is amongst the best in the industry. CF outperforms 91.46% of its industry peers.
CF's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.6%
PM (TTM) N/A
GM 94.51%
OM growth 3Y-17.7%
OM growth 5Y0.9%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.16%
GM growth 5Y0.29%
CF.CA Yearly Profit, Operating, Gross MarginsCF.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50

4

2. Health

2.1 Basic Checks

CF has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, CF has more shares outstanding
CF has a worse debt/assets ratio than last year.
CF.CA Yearly Shares OutstandingCF.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
CF.CA Yearly Total Debt VS Total AssetsCF.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 0.62, we must say that CF is in the distress zone and has some risk of bankruptcy.
CF's Altman-Z score of 0.62 is fine compared to the rest of the industry. CF outperforms 62.20% of its industry peers.
The Debt to FCF ratio of CF is 3.45, which is a good value as it means it would take CF, 3.45 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 3.45, CF is in the better half of the industry, outperforming 74.39% of the companies in the same industry.
A Debt/Equity ratio of 1.39 is on the high side and indicates that CF has dependencies on debt financing.
CF has a Debt to Equity ratio (1.39) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF 3.45
Altman-Z 0.62
ROIC/WACCN/A
WACCN/A
CF.CA Yearly LT Debt VS Equity VS FCFCF.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B

2.3 Liquidity

CF has a Current Ratio of 1.19. This is a normal value and indicates that CF is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Current ratio value of 1.19, CF is doing good in the industry, outperforming 62.20% of the companies in the same industry.
CF has a Quick Ratio of 1.19. This is a normal value and indicates that CF is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.19, CF is in the better half of the industry, outperforming 62.20% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.19
Quick Ratio 1.19
CF.CA Yearly Current Assets VS Current LiabilitesCF.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

6

3. Growth

3.1 Past

CF shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 47.62%, which is quite impressive.
CF shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -5.21% yearly.
Looking at the last year, CF shows a quite strong growth in Revenue. The Revenue has grown by 19.63% in the last year.
Measured over the past years, CF shows a small growth in Revenue. The Revenue has been growing by 7.65% on average per year.
EPS 1Y (TTM)47.62%
EPS 3Y-37.34%
EPS 5Y-5.21%
EPS Q2Q%-20%
Revenue 1Y (TTM)19.63%
Revenue growth 3Y-4.73%
Revenue growth 5Y7.65%
Sales Q2Q%12.76%

3.2 Future

Based on estimates for the next years, CF will show a very strong growth in Earnings Per Share. The EPS will grow by 35.18% on average per year.
Based on estimates for the next years, CF will show a quite strong growth in Revenue. The Revenue will grow by 8.31% on average per year.
EPS Next Y67.24%
EPS Next 2Y35.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.78%
Revenue Next 2Y8.31%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
CF.CA Yearly Revenue VS EstimatesCF.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B
CF.CA Yearly EPS VS EstimatesCF.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 1 1.5 2 2.5

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 17.42 indicates a rather expensive valuation of CF.
CF's Price/Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.41, CF is valued a bit cheaper.
CF is valuated reasonably with a Price/Forward Earnings ratio of 10.42.
65.85% of the companies in the same industry are more expensive than CF, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CF to the average of the S&P500 Index (35.19), we can say CF is valued rather cheaply.
Industry RankSector Rank
PE 17.42
Fwd PE 10.42
CF.CA Price Earnings VS Forward Price EarningsCF.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, CF is valued cheaper than 98.78% of the companies in the same industry.
Industry RankSector Rank
P/FCF 2.79
EV/EBITDA -2.6
CF.CA Per share dataCF.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CF's earnings are expected to grow with 35.18% in the coming years.
PEG (NY)0.26
PEG (5Y)N/A
EPS Next 2Y35.18%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

CF has a Yearly Dividend Yield of 3.07%.
CF's Dividend Yield is comparable with the industry average which is at 5.35.
Compared to an average S&P500 Dividend Yield of 2.35, CF pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.07%

5.2 History

On average, the dividend of CF grows each year by 11.34%, which is quite nice.
CF has been paying a dividend for at least 10 years, so it has a reliable track record.
CF has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)11.34%
Div Incr Years0
Div Non Decr Years4
CF.CA Yearly Dividends per shareCF.CA Yearly Dividends per shareYearly Dividends per share 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

The earnings of CF are negative and hence is the payout ratio. CF will probably not be able to sustain this dividend level.
The dividend of CF is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-244.16%
EPS Next 2Y35.18%
EPS Next 3YN/A
CF.CA Yearly Income VS Free CF VS DividendCF.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B

CANACCORD GENUITY GROUP INC

TSX:CF (7/11/2025, 7:00:00 PM)

10.8

-0.26 (-2.35%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)06-04 2025-06-04/amc
Earnings (Next)07-31 2025-07-31
Inst Owners12.85%
Inst Owner ChangeN/A
Ins Owners4.54%
Ins Owner ChangeN/A
Market Cap1.11B
Analysts83.33
Price Target11.65 (7.87%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.07%
Yearly Dividend0.75
Dividend Growth(5Y)11.34%
DP-244.16%
Div Incr Years0
Div Non Decr Years4
Ex-Date06-20 2025-06-20 (0.085)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-28.43%
Min EPS beat(2)-31.23%
Max EPS beat(2)-25.64%
EPS beat(4)0
Avg EPS beat(4)-26.88%
Min EPS beat(4)-38.93%
Max EPS beat(4)-11.74%
EPS beat(8)1
Avg EPS beat(8)-25.31%
EPS beat(12)2
Avg EPS beat(12)-28.22%
EPS beat(16)6
Avg EPS beat(16)-16.16%
Revenue beat(2)0
Avg Revenue beat(2)-2.88%
Min Revenue beat(2)-3.28%
Max Revenue beat(2)-2.47%
Revenue beat(4)2
Avg Revenue beat(4)48413.3%
Min Revenue beat(4)-3.28%
Max Revenue beat(4)97433.2%
Revenue beat(8)3
Avg Revenue beat(8)24203.3%
Revenue beat(12)4
Avg Revenue beat(12)16133.3%
Revenue beat(16)7
Avg Revenue beat(16)12101%
PT rev (1m)0%
PT rev (3m)3.01%
EPS NQ rev (1m)-10.14%
EPS NQ rev (3m)-10.14%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.94%
Valuation
Industry RankSector Rank
PE 17.42
Fwd PE 10.42
P/S 0.63
P/FCF 2.79
P/OCF 2.33
P/B 1.15
P/tB N/A
EV/EBITDA -2.6
EPS(TTM)0.62
EY5.74%
EPS(NY)1.04
Fwd EY9.6%
FCF(TTM)3.87
FCFY35.8%
OCF(TTM)4.64
OCFY42.95%
SpS17.25
BVpS9.36
TBVpS-0.71
PEG (NY)0.26
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.43%
ROE -3.01%
ROCE 8.88%
ROIC 3.49%
ROICexc 10%
ROICexgc N/A
OM 11.6%
PM (TTM) N/A
GM 94.51%
FCFM 22.41%
ROA(3y)-0.81%
ROA(5y)0.75%
ROE(3y)-5.02%
ROE(5y)5.02%
ROIC(3y)3.66%
ROIC(5y)7.72%
ROICexc(3y)16.73%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.63%
ROCE(5y)16.38%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-17.7%
OM growth 5Y0.9%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.16%
GM growth 5Y0.29%
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 1.39
Debt/FCF 3.45
Debt/EBITDA 4.77
Cap/Depr 105.69%
Cap/Sales 4.48%
Interest Coverage 1.57
Cash Conversion 169.8%
Profit Quality N/A
Current Ratio 1.19
Quick Ratio 1.19
Altman-Z 0.62
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)61.72%
Cap/Depr(5y)45.52%
Cap/Sales(3y)2.7%
Cap/Sales(5y)1.83%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)47.62%
EPS 3Y-37.34%
EPS 5Y-5.21%
EPS Q2Q%-20%
EPS Next Y67.24%
EPS Next 2Y35.18%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)19.63%
Revenue growth 3Y-4.73%
Revenue growth 5Y7.65%
Sales Q2Q%12.76%
Revenue Next Year12.78%
Revenue Next 2Y8.31%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y0.87%
EBIT growth 3Y-21.6%
EBIT growth 5Y8.62%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y1128.08%
FCF growth 3Y16.83%
FCF growth 5Y1.82%
OCF growth 1Y3791.78%
OCF growth 3Y21.79%
OCF growth 5Y5.22%